Galapagos receives transparency notification from FMR LLC
August 18 2022 - 3:01PM
Galapagos receives transparency notification from FMR LLC
Mechelen, Belgium;
18 August
2022,
22.01
CET; regulated information – Galapagos NV
(Euronext & NASDAQ: GLPG) received a
transparency notification from FMR LLC.
Pursuant to Belgian transparency legislation1,
Galapagos received a transparency notification on 15 August 2022
from FMR LLC, who notified that it holds 3,740,842 of Galapagos’
voting rights, consisting of 3,740,842 ordinary shares. FMR LLC
controls investment funds FIAM Holdings LLC, Fidelity Management
& Research Company LLC, Fidelity Management Trust Company and
Strategic Advisers LLC, of which Fidelity Management & Research
Company LLC increased its position to 3,303,128 voting rights, and
no longer holds any equivalent financial instruments, and Strategic
Advisers LLC decreased its position to 10,082 voting rights. FMR
LLC's holding of 3,740,842 Galapagos' voting rights represents
5.69% of Galapagos' currently outstanding 65,728,511 shares. FMR
LLC thus remains above the 5% threshold of Galapagos’ voting rights
considering the change in the nature of holdings. The full
transparency notice is available on the Galapagos website.
About
Galapagos
Galapagos is a fully integrated biotechnology
company focused on discovering, developing, and commercializing
innovative medicines. We are committed to improving patients’ lives
worldwide by targeting diseases with high unmet needs. Our R&D
capabilities cover multiple drug modalities, including small
molecules and cell therapies. Our portfolio comprises discovery
through to Phase 3 programs in inflammation, oncology, fibrosis,
and other indications. Our first medicine for rheumatoid arthritis
and ulcerative colitis is approved and available in the European
Union (including Norway), Great Britain and Japan. For additional
information, please visit www.glpg.com or follow us on LinkedIn or
Twitter.ContactInvestors:Sofie
Van GijselHead of Investor Relations+1 781 296 1143
Sandra CauwenberghsDirector Investor Relations+32 495 58 46
63ir@glpg.com
Media:Marieke VermeerschHead of Corporate
Communication+32 479 490 603media@glpg.com
1 Belgian Act of 2 May 2007 on the disclosure of major
shareholdings in issuers whose shares are admitted to trading on a
regulated market
Galapagos (TG:GXE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Galapagos (TG:GXE)
Historical Stock Chart
From Oct 2023 to Oct 2024